Stocks and Investing Stocks and Investing
Mon, January 8, 2018
Fri, January 5, 2018

Jacob Hughes Downgraded (TEVA) to Sell on, Jan 5th, 2018


Published on 2024-10-26 01:46:54 - WOPRAI, Jacob Hughes
  Print publication without navigation


Jacob Hughes of Wells Fargo, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Sell on, Jan 5th, 2018.

Jacob has made no other calls on TEVA in the last 4 months.



There are 10 other peers that have a rating on TEVA. Out of the 10 peers that are also analyzing TEVA, 5 agree with Jacob's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, December 15th, 2017
  • Vamil Divan of "Credit Suisse" Upgraded from Sell to Hold on, Friday, December 15th, 2017
  • Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
  • Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
  • Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017


These are the ratings of the 5 analyists that currently disagree with Jacob


  • Liav Abraham of "Citigroup" Upgraded from Hold to Strong Buy on, Thursday, January 4th, 2018
  • Ami Fadia of "Leerink Swann" Initiated at Sell and Held Target at $15 on, Tuesday, January 2nd, 2018
  • Jami Rubin of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Friday, December 15th, 2017
  • Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
  • Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017

Contributing Sources